Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02807272
Title Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia (CMML)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kura Oncology, Inc.
Indications

myelodysplastic/myeloproliferative neoplasm

Therapies

Tipifarnib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.